Guidance by date
To find out more about guidance NICE has published on a particular date, choose from the list below.
Use the Search NICE guidance tool for quick and easy access to all NICE guidance and guidance in development. The guidance search tool is located on the right. See also HDA publications.
July 2010
| Ref | Title | Type |
|---|---|---|
| TA194 | Bone loss (therapy-induced) in non-metastatic prostate cancer - denosumab (terminated appraisal) | Technology appraisals |
| CG103 | Delirium | Clinical guidelines |
| TA191 | Gastric cancer (advanced) - capecitabine | Technology appraisals |
| TA193 | Leukaemia (chronic lymphocytic, relapsed) - rituximab | Technology appraisals |
| TA192 | Lung cancer (non-small-cell, first line) - gefitinib | Technology appraisals |
| CG104 | Metastatic malignant disease of unknown primary origin | Clinical guidelines |
| CG105 | Motor neurone disease - non-invasive ventilation | Clinical guidelines |
| IPG352 | Percutaneous mitral valve annuloplasty | Interventional procedures |
| IPG353 | Percutaneous radiofrequency ablation of renal cancer | Interventional procedures |
| IPG354 | Shoulder resurfacing arthroplasty | Interventional procedures |
| PH27 | Weight management before, during and after pregnancy | Public health guidance |
This page was last updated: 08 February 2012
